Department of Pharmacy, Tokyo Women's Medical University Hospital, Tokyo 162-8666, Japan.
Department of Pharmacy, Mie University Hospital, Mie 514-8507, Japan.
Int J Environ Res Public Health. 2022 Feb 22;19(5):2516. doi: 10.3390/ijerph19052516.
Under the Japanese health insurance system, medicines undergoing therapeutic drug monitoring (TDM) can be billed for medical fees if they meet the specified requirements. In Japan, TDM of vancomycin, teicoplanin, aminoglycosides, and voriconazole, which are used for the treatment of infectious diseases, is common practice. This means the levels of antibiotics are measured in-house using chromatography or other methods. In some facilities, the blood and/or tissue concentrations of other non-TDM drugs are measured by HPLC and are applied to treatment, which is necessary for personalized medicine. This review describes personalized medicine based on the use of chromatography as a result of the current situation in Japan.
在日本的医疗保险制度下,如果符合特定要求,正在进行治疗药物监测(TDM)的药物可以收取医疗费用。在日本,治疗感染性疾病常用的万古霉素、替考拉宁、氨基糖苷类和伏立康唑等药物都需要进行 TDM。这意味着使用色谱法或其他方法在内部测量抗生素的水平。在一些医疗机构中,还会通过 HPLC 测量其他非 TDM 药物的血液和/或组织浓度,并将其应用于治疗,这是个性化药物治疗所必需的。本文综述了基于色谱法的个性化药物治疗,这是当前日本的现状。